PDCD1 and neoplasm: Furthermore, TIM-3 and PD-1 inhibitors increased the percentage of tumor-infiltrating Th1 cells while reducing Th2 cell proportions, and led to a noticeable decrease in tumor-infiltrating Tregs compared to isotype controls (Fig. 5D–F and Supplementary Fig. 5).